GlassScriptPhysician profile
Jerome G Gonzalez
NPI 1427027408
$2,118.42
in general payments reported to CMS, 2019-2025
11 companies · $598 in 2025
The $598 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $132 · 2021: $170 · 2022: $347 · 2023: $326 · 2024: $438 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,362.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $644.61 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $476.52 | 2019-2025 | Dupixent |
| Optinose US, INC. | $276.87 | 2019-2024 | |
| Stryker Corporation | $239.98 | 2025 | Scopis Ent, Clarifix, Xpress Loprofile |
| Abiomed | $148.13 | 2024 | Impella |
| Acclarent, INC | $96.35 | 2019-2022 | |
| Inspire Medical Systems, INC. | $79.53 | 2023-2024 | Inspire |
| Horizon Therapeutics Plc | $53.33 | 2021-2023 | Krystexxa |
| Aerin Medical INC. | $48.72 | 2019-2024 | |
| Biom'Up France Sas | $37.90 | 2021 | |
| Baxter Healthcare | $16.48 | 2024 | Perclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerome Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.